Tiziana Life Sciences Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +17.2% | +249.1% | -84.2% | +43.8% | -39.1% | +234.5% | -168.0% | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -11.1% | +422.5% | -88.5% | -16.7% | -45.0% | +2,464.1% | – | – | – | – | – | – | +21.5% | +49.9% | +1,462.8% | -64.1% | +57.1% | -63.8% | – | – | – | |
| – | – | – | – | – | – | – | +40.7% | +157.9% | -79.6% | +80.0% | -37.5% | -310.5% | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -43.8% | +40.2% | +63.0% | +10.9% | -10.8% | -44.1% | -80.6% | – | – | – | – | – | +1,073.1% | -68.3% | +58.1% | +17.7% | -32.2% | +118.6% | +118.6% | -10.6% | -35.6% | -49.0% | +96.6% | |
| – | – | – | – | – | – | – | – | – | -8.7% | -22.9% | -38.9% | – | – | +42.5% | -37.6% | +3,573.7% | +971.1% | -70.1% | +114.1% | -93.9% | +40.5% | +189.6% | -93.6% | +41.4% | -100.0% | – | – | |
| – | +145.2% | +398.8% | -0.8% | -4.1% | -76.5% | +179.4% | +47.5% | +11.4% | -6.9% | -31.8% | -50.2% | -483.7% | – | +42.5% | -37.6% | +865.7% | +362.0% | -42.9% | +13.1% | +20.2% | -4.1% | +301.2% | -3.1% | -51.5% | +26.8% | -30.5% | +33.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -50.0% | +300.0% | -37.5% | +100.0% | -20.0% | -37.5% | -40.0% | +33.3% | +24.0% | -100.0% | – | – | – | +85.8% | -62.9% | -11.7% | +37.1% | +681.1% | +365.2% | -45.5% | -96.4% | +46.9% | -52.5% | +200.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -4.3% | -135.4% | – | – | – | – | – | – | – | – | – | – | -83.8% | -74.3% | -101.5% | – | – | – | – | – | – | – | – | – | -30.0% | -960.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.